Skip to main content

Advertisement

Table 2 Transcript abundance measurements for primary normal BEC and BC tissues

From: Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21waf1/cip1 among human bronchogenic carcinomas

Sample ID Diagnosis Cell Type E2F1 p73α p21
63 NC N 270 850 14,000
282 NC N 540 640 10,000
64 NC N 2,000 400 10,000
285 NC N 2,500 870 3,100
257 NC N 270 5,200 12,000
156 NC N 750 1,000 25,000
194 NC N 290 3,800 3,500
150 NC N 160 3,700 11,000
136 NC N 700 31 9,100
261 NC N 250 3,100 30,000
191 C N 150 900 13,000
158 C N 190 2,200 11,000
146 C N 230 2,600 9,100
34 C N 570 4,400 12,000
212 C N 600 5,300 35,000
274 C Sq 730 1 7,000
279 C A 1,200 1 4,000
190 C BA 6,600 3 27,000
102 C A 12,000 21 21,000
165 C SC 36,000 4,300 16,000
123 C Sq 54,000 5,500* 90,000
277* C A 120,000 100 2,000
  1. NC, non-cancer; C, cancer; N, normal; Sq, squamous carcinoma; A, adenocarcinoma; BA, bronchoalveolar carcinoma; SC, small cell carcinoma. Non-detectable TA were entered as 1 to allow plotting on a logarithmic scale. Normal BEC are grouped by diagnosis and cell type. BC tissues are grouped by increasing E2F1 TA. All values are in units of molecules/106 molecules β-actin and represent the mean from three independent measurements. *This value represents the mean from two measurements due to insufficient sample.